Tamra Starner
Nurse Practitioner · Monroe, MINPI 1811199078
Payments from drug & device makers
Across 127 payments — averaging $15.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$551
- Lilly USA, LLC$432
- AbbVie$356
- Novartis$127
- Amgen$103
- Astellas Pharma US Inc$70
- plus $392 from 15 others
What the payments were for
- Food & beverage$2,01899%
- Education$121%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 38 | $551 |
| Lilly USA, LLC | 30 | $432 |
| AbbVie | 19 | $356 |
| Novartis | 7 | $127 |
| Amgen | 6 | $103 |
| Astellas Pharma US Inc | 4 | $70 |
| GSK | 4 | $57 |
| Pfizer | 3 | $51 |
| Optinose US, Inc. | 2 | $44 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $42 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $35 |
| Inogen, Inc. | 1 | $23 |
| Dexcom, Inc. | 1 | $22 |
| Axsome Therapeutics, Inc. | 1 | $21 |
| Amarin Pharma, Inc. | 1 | $17 |
| Shield Therapeutics Inc | 1 | $16 |
| Aimmune Therapeutics, Inc. | 1 | $15 |
| Biohaven Pharmaceuticals, Inc. | 1 | $13 |
| AstraZeneca | 1 | $13 |
| Abbott | 1 | $12 |
| Jazz Pharmaceuticals Inc. | 1 | $12 |
How this compares
$2,030 in reported general payments places this provider in the 85th percentile of 3,351 nurse practitioner providers in Michigan.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 85 | $109,260 |
| OzempicSemaglutide | 47 | $55,584 |
| TrulicityDulaglutide | 29 | $43,641 |
| JardianceEmpagliflozin | 43 | $42,159 |
| EliquisApixaban | 26 | $33,127 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 41 | $28,389 |
| XareltoRivaroxaban | 20 | $20,117 |
| JanuviaSitagliptin Phosphate | 15 | $18,575 |
| LinzessLinaclotide | 18 | $11,735 |
| Emgality PenGalcanezumab-Gnlm | 11 | $7,642 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 48 | $7,147 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 170 | $6,310 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 235 | $5,203 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 141 | $4,415 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 18 | $2,483 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity | $432 | $152,901114 claims |
| Novo NordiskOzempic | $551 | $55,58447 claims |
| PfizerEliquis | $51 | $33,12726 claims |
| GSKTrelegy Ellipta | $57 | $28,38941 claims |
| AbbVieLinzess, Armour Thyroid | $356 | $12,59837 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 3,351 nurse practitioner providers in Michigan.
Other nurse practitioner in Monroe
- Davida KrugerDetroit$1.8M
- Kari HillSpring Lake$426K
- Kyle FarrPlymouth$243K
- Linda SpencerTroy$217K
- Ellen DillardDetroit$168K
- Golbon AghamohammadiDetroit$157K
- Abubakir BabanDearborn$143K
- Elizabeth KirshnerAnn Arbor$119K
- Lisa Astalos ChismWoodhaven$103K
- Martha GoetzPetoskey$101K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.